Wolfgang Hoyer

Title: Wolfgang Hoyer: Innovator in Amyloid-Beta Research

Introduction

Wolfgang Hoyer is a distinguished inventor based in Düsseldorf, Germany. He has made significant contributions to the field of protein misfolding diseases, particularly through his innovative research on amyloid-beta aggregation. His work aims to advance the understanding and treatment of neurodegenerative diseases.

Latest Patents

Wolfgang Hoyer holds a patent titled "Method for identifying inhibitors of primary nucleation of amyloid-beta aggregation." This patent describes a method for identifying inhibitors of the primary nucleation of amyloid beta aggregation. The method involves providing an A-beta species in solution or in a buffer and determining the amyloid-beta aggregation. The A-beta species comprises two A-beta monomer units with a linker arranged between them. Additionally, the patent includes a method for analyzing the aggregation of monomers related to protein misfolding diseases and provides a kit for this purpose. He has 1 patent to his name.

Career Highlights

Wolfgang Hoyer is affiliated with Forschungszentrum Jülich GmbH, where he conducts his research. His work at this research center has positioned him as a key figure in the study of amyloid-beta and its implications in neurodegenerative diseases.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Wolfgang Hoyer's innovative research and patent contributions are vital in the ongoing battle against neurodegenerative diseases. His work continues to inspire advancements in the field of protein misfolding and amyloid-beta aggregation.